Reversible binding of heparin to the loop peptide of endotoxin neutralizing protein

被引:4
作者
Ridge, RJ [1 ]
Paus, EJ [1 ]
Novitsky, TJ [1 ]
Ketchum, PA [1 ]
机构
[1] Associates Cape Cod Inc, Falmouth, MA 02540 USA
来源
JOURNAL OF ENDOTOXIN RESEARCH | 2000年 / 6卷 / 01期
关键词
D O I
10.1177/09680519000060010301
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endotoxin neutralizing protein (ENP) from Limulus polyphemus is an amphipathic, 11.8 kDa protein with an isoelectric point of 10.2. ENP neutralizes lipopolysaccharide (LPS) and possesses antibacterial activity against Gram-negative bacteria. Heparin binds to ENP and blocks its LPS-neutralizing activity. The relative blocking activity of heparin is equal to low molecular weight heparin and polyanetholsulfonic acid >heparan sulfate > chondroitin sulfate A > chondroitin sulfate C. Endoproteinase Glu-C hydrolysis of recombinant ENP results in four major peptides, three of which are seen following separation on reversed phase HPLC. Heparin binds to the loop peptide (31-72), which includes the heparin binding consensus sequence XBBXBX between the two cysteine residues of ENP. When heparin is added to the digest and then applied to a C18 column, the loop peptide is bound; however, it dissociates and elutes with either 5 M NaCl or 0.1 M sodium phosphate, demonstrating reversible binding to heparin. LPS and lipid A both bind to the loop peptide and remove it from digests of ENP; however, neither complex could be dissociated by salt or sodium phosphate, Heparin,LPS, and lipid A individually bind to the same site on ENP.
引用
收藏
页码:17 / 23
页数:7
相关论文
共 25 条
[1]  
AKETAGAWA J, 1986, J BIOL CHEM, V261, P7357
[2]   PEPTIDE DERIVATIVES OF 3 DISTINCT LIPOPOLYSACCHARIDE-BINDING PROTEINS INHIBIT LIPOPOLYSACCHARIDE-INDUCED TUMOR-NECROSIS-FACTOR-ALPHA SECRETION IN-VITRO [J].
BATTAFARANO, RJ ;
DAHLBERG, PS ;
RATZ, CA ;
JOHNSTON, JW ;
GRAY, BH ;
HASEMAN, JR ;
MAYO, KH ;
DUNN, DL .
SURGERY, 1995, 118 (02) :318-324
[3]   MOLECULAR MODELING OF PROTEIN-GLYCOSAMINOGLYCAN INTERACTIONS [J].
CARDIN, AD ;
WEINTRAUB, HJR .
ARTERIOSCLEROSIS, 1989, 9 (01) :21-32
[4]   Lactoferrin-lipopolysaccharide interaction: Involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide [J].
ElassRochard, E ;
Roseanu, A ;
Legrand, D ;
Trif, M ;
Salmon, V ;
Motas, C ;
Montreuil, J ;
Spik, G .
BIOCHEMICAL JOURNAL, 1995, 312 :839-845
[5]   CRYSTAL-STRUCTURE OF AN ENDOTOXIN-NEUTRALIZING PROTEIN FROM THE HORSESHOE-CRAB, LIMULUS ANTI-LPS FACTOR, AT 1.5 ANGSTROM RESOLUTION [J].
HOESS, A ;
WATSON, S ;
SIBER, GR ;
LIDDINGTON, R .
EMBO JOURNAL, 1993, 12 (09) :3351-3356
[6]   MOLECULAR MECHANISM OF HEMOLYMPH CLOTTING SYSTEM IN LIMULUS [J].
IWANAGA, S ;
MIYATA, T ;
TOKUNAGA, F ;
MUTA, T .
THROMBOSIS RESEARCH, 1992, 68 (01) :1-32
[7]  
Iwanaga S, 1998, J BIOCHEM, V123, P1
[8]   SYNTHETIC PEPTIDES THAT MIMIC THE BINDING-SITE OF HORSESHOE-CRAB ANTILIPOPOLYSACCHARIDE FACTOR [J].
KLOCZEWIAK, M ;
BLACK, KM ;
LOISELLE, P ;
CAVAILLON, JM ;
WAINWRIGHT, N ;
WARREN, HS .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (06) :1490-1497
[9]   INSECT IMMUNITY - ISOLATION FROM IMMUNE BLOOD OF THE DIPTERAN PHORMIA-TERRANOVAE OF 2 INSECT ANTIBACTERIAL PEPTIDES WITH SEQUENCE HOMOLOGY TO RABBIT LUNG MACROPHAGE BACTERICIDAL PEPTIDES [J].
LAMBERT, J ;
KEPPI, E ;
DIMARCQ, JL ;
WICKER, C ;
REICHHART, JM ;
DUNBAR, B ;
LEPAGE, P ;
VANDORSSELAER, A ;
HOFFMANN, J ;
FOTHERGILL, J ;
HOFFMANN, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (01) :262-266
[10]   HUMAN CAP18 - A NOVEL ANTIMICROBIAL LIPOPOLYSACCHARIDE-BINDING PROTEIN [J].
LARRICK, JW ;
HIRATA, M ;
BALINT, RF ;
LEE, J ;
ZHONG, J ;
WRIGHT, SC .
INFECTION AND IMMUNITY, 1995, 63 (04) :1291-1297